← All Mei Pharma, INC filings

Mei Pharma, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
MEIP
Mei Pharma, INC
DEFA14A: Lite Strategy Board Boosts Independent Directors
Lite Strategy, Inc. announced a supplement to its proxy statement, confirming Board member Joshua Riezman's independence, increasing the total independent directors to four out of six.
NASDAQ
MEIP
Mei Pharma, INC
DEFA14A: LITE STRATEGY Files Definitive Proxy Statement
LITE STRATEGY, INC. has filed a Definitive Proxy Statement with the SEC.
NASDAQ
MEIP
Mei Pharma, INC
DEF: Lite Strategy Sets 2026 Annual Meeting Agenda
Lite Strategy, Inc. announces its virtual 2026 Annual Meeting of Stockholders to vote on director elections, executive compensation, auditor ratification, and a new equity compensation plan.
NASDAQ
MEIP
Mei Pharma, INC
DEFA14A: MEI Pharma Sets Date for Annual Stockholder Meeting, Outlines Key Proposals
MEI Pharma will hold its annual stockholder meeting virtually on January 30, 2025, to vote on director elections, executive compensation, and auditor ratification.
NASDAQ
MEIP
Mei Pharma, INC
DEF: MEI Pharma Sets Virtual Annual Meeting for January 30, 2025, Outlines Director Elections and Executive Compensation
MEI Pharma will hold its annual stockholder meeting virtually on January 30, 2025, to elect directors, approve executive compensation, and ratify the appointment of auditors.